| Mechanisms of membrane transport of folates into cells and across epithelia R Zhao, N Diop-Bove, M Visentin, ID Goldman Annual review of nutrition 31 (1), 177-201, 2011 | 391 | 2011 |
| The antifolates M Visentin, R Zhao, ID Goldman Hematology/Oncology Clinics 26 (3), 629-648, 2012 | 295 | 2012 |
| Lipid accumulation and chronic kidney disease Z Gai, T Wang, M Visentin, GA Kullak-Ublick, X Fu, Z Wang Nutrients 11 (4), 722, 2019 | 275 | 2019 |
| The intestinal absorption of folates M Visentin, N Diop-Bove, R Zhao, ID Goldman Annual review of physiology 76 (1), 251-274, 2014 | 215 | 2014 |
| Molecular mechanisms of colistin-induced nephrotoxicity Z Gai, SL Samodelov, GA Kullak-Ublick, M Visentin Molecules 24 (3), 653, 2019 | 122 | 2019 |
| Effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation Z Gai, M Visentin, T Gui, L Zhao, WE Thasler, S Häusler, I Hartling, ... Molecular Pharmacology 94 (2), 802-811, 2018 | 86 | 2018 |
| Drug-induced bile duct injury M Visentin, D Lenggenhager, Z Gai, GA Kullak-Ublick Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 86 | 2018 |
| Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy E Cecchin, M Agostini, S Pucciarelli, A De Paoli, V Canzonieri, R Sigon, ... The pharmacogenomics journal 11 (3), 214-226, 2011 | 80 | 2011 |
| Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity Z Gai, M Visentin, C Hiller, E Krajnc, T Li, J Zhen, GA Kullak-Ublick Antimicrobial agents and chemotherapy 60 (9), 5573-5580, 2016 | 50 | 2016 |
| Organic cation transporters in human physiology, pharmacology, and toxicology SL Samodelov, GA Kullak-Ublick, Z Gai, M Visentin International journal of molecular sciences 21 (21), 7890, 2020 | 48 | 2020 |
| Substrate-and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1) M Visentin, MH Chang, MF Romero, R Zhao, ID Goldman Molecular pharmacology 81 (2), 134-142, 2012 | 43 | 2012 |
| The role of mitochondria in drug-induced kidney injury Z Gai, T Gui, GA Kullak-Ublick, Y Li, M Visentin Frontiers in physiology 11, 1079, 2020 | 34 | 2020 |
| Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5) M Visentin, Z Gai, A Torozi, C Hiller, GA Kullak-Ublick Drug Metabolism and Disposition 45 (12), 1240-1244, 2017 | 31 | 2017 |
| Obeticholic acid ameliorates valproic acid–induced hepatic steatosis and oxidative stress Z Gai, E Krajnc, SL Samodelov, M Visentin, GA Kullak-Ublick Molecular pharmacology 97 (5), 314-323, 2020 | 29 | 2020 |
| Farnesoid X receptor activation induces the degradation of hepatotoxic 1‐deoxysphingolipids in non‐alcoholic fatty liver disease Z Gai, T Gui, I Alecu, MA Lone, T Hornemann, Q Chen, M Visentin, ... Liver International 40 (4), 844-859, 2020 | 28 | 2020 |
| Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2 M Visentin, B Stieger, M Merz, GA Kullak-Ublick Journal of Pharmacology and Experimental Therapeutics 355 (2), 145-151, 2015 | 27 | 2015 |
| The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor M Visentin, ES Unal, R Zhao, ID Goldman Cancer chemotherapy and pharmacology 72, 597-606, 2013 | 25 | 2013 |
| Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate M Visentin, R Zhao, ID Goldman Molecular pharmacology 82 (2), 209-216, 2012 | 23 | 2012 |
| Renal reabsorption of folates: pharmacological and toxicological snapshots SL Samodelov, Z Gai, GA Kullak-Ublick, M Visentin Nutrients 11 (10), 2353, 2019 | 21 | 2019 |
| Plasma membrane cholesterol regulates the allosteric binding of 1-methyl-4-phenylpyridinium to organic cation transporter 2 (SLC22A2) S Hörmann, Z Gai, GA Kullak-Ublick, M Visentin Journal of Pharmacology and Experimental Therapeutics 372 (1), 46-53, 2020 | 18 | 2020 |
